 mortal patient flecainid encainid supraventricular arrhythmia recent clinic trial class Ic antiarrhythm drug mortal risk patient new myocardi infarct ventricular arrhythmia purpos studi mortal risk use drug patient supraventricular arrhythmia data respect pharmaceut sponsor mortal drug unit foreign protocol patient supraventricular arrhythmia mortal encainid popul patient flecainid popul patient research arrhythmia clinic duke popul patient nine death combin encainide-flecainid popul death duke popul follow-up period day day surviv function popul kaplan-mei techniqu hazard ratio combin encainide-flecainid popul rel duke popul confid interv descript comparison excess mortal flecainid encainid patient supraventricular arrhythmia